Cite
HARVARD Citation
Tarhini, A. et al. (n.d.). 312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition. Journal for immunotherapy of cancer. p. A339. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tarhini, A. et al. (n.d.). 312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition. Journal for immunotherapy of cancer. p. A339. [Online].